First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...
A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...
Hospitals and some insurers face big hits to their finances if Republicans eliminate or scale back parts of the Affordable ...
Amid alarm over how a Trump administration, including RFK Jr., might interfere with public health, a Kennedy relative is ...
The daily ration for sugar was the equivalent of about 6 to 7 teaspoons of sugar, an amount comparable to today’s dietary ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
In the effort to expand approaches to treating Alzheimer’s beyond targeting amyloid, some companies have sought to target ...
Novo Nordisk’s Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, new data show.
People in science are increasingly concerned about how wading into partisan politics may further erode trust in their field.
Chiropractors for RFK —Three appeals in a pod —The FDA shortage saga —The ghost of elections past And more! Join the conversation here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback